Micromon’s DNA sequencing service is one of the key core facilities in Australia and has a nationwide reputation for its high quality data and reliable, customer-focused service. Micromon has an established high-throughput sequencing facility utilising Illumina Next-generation platform technology.

The Victorian Cancer Biobank is a not-for-profit consortium of tissue banks, supported by the Victorian Government through the Victorian Cancer Agency. Our purpose is to provide high quality, ethically obtained biospecimens to support research that will lead to improvements in cancer diagnosis and treatment.

The APN Histopathology and Organ Pathology service helps researchers across Australia in whole organ and histological analysis of mouse models and mice at specific developmental stages. Staff providing the service have extensive histology, diagnostic and electronic imaging experience.

The platform provides for electrophysiological investigation by sharp electrode and patch-clamp recordings. Imaging includes 3 confocal microscopes, laser microdissection, conventional multi-wavelength fluorescence and high resolution white light microscopy.

Encompasses and uses the CSIRO Biomolecular Interaction Facility and the CSIRO Bio21 Crystallisation Centre to screen libraries of fragments as the first step towards rational drug design

Observation of cells non-invasively in animals making it a very useful tool for work on bone biology.

The AAHL Collaborative Biosecurity Research Facility (ACBRF) provides world-class infrastructure and related technology platforms for researchers conducting projects requiring a high biocontainment/ biosecure environment.

The MCRI GRF has collections of three PAC/BAC libraries; RPCI-1 Human PAC library, RPCI-11 Human Male BAC Library and RPCI-23 Female (C57BL/6J) Mouse BAC Library.

This shared resource – incorporating the AAHL Biosecurity Microscopy Facility (ABMF) – provides world-class infrastructure and related technology platforms for researchers conducting projects requiring a high biocontainment/biosecure environment.

The Victorian Brain Bank Network (VBBN) has the function of providing Australian and International researchers with easy access to clinically and neuropathologically well-characterised post-mortem human brains and related samples.

The Burnet ImmunoMonitoring Facility is accredited in NATA’s R&D Program and offers immunological testing and sample biobanking for vaccine manufacturers, biotechnology and pharmaceutical companies, universities, and research institutes involved in translational research and development of novel therapies.

High content screening is a sophisticated, state-of-the-art method used to identify modulations of cell biology and develop new therapeutics. The new High Content Cell Discovery and Screening Facility (HCSF) based at MIMR combines the advantages of high content screening with the development of genome-wide RNAi libraries and robotics to facilitate [...]

The Molecular Genomics Core Facility encompasses both the Microarray Core facility and the Next Generation DNA Sequencing Core Facility. For both facilities, services to external researchers are offered when spare capacity allows. Microarray We offer both full and partial services to researchers who wish to use Affymetrix Gene Expression arrays [...]

This NATA accredited facility offers immunohistochemistry, biomarker validation, flow cytometry, blood morphology, tissue microarrays, human pathology opinion, analysis of methylation and molecular pathology testing as well as standard haematological and biochemical laboratory services. Access by: Research collaboration. Fee for service.

Neuro Research Services provides academic and industry researchers access to a comprehensive rodent neuro-phenotyping facility. Behavioural equipment, including video tracking software systems, enables the assessment of rodent motor function, memory, learning, addiction, anxiety, depression and nociception. This is complemented by neuro-histology and an advanced microscopy service that enables the full [...]

Mice can be shipped to our Facility to obtain a range of complex exams (on a fee-for-service basis) used to characterize mouse metabolism, blood composition including hormones, energy balance and physical activity, eating and exercise, insulin resistance, metabolic fluxes and physiology. Many tests are done in living animals and are [...]

The HTCS Facility houses a Lead Discovery library currently containing ~200,000 compounds and robotics platforms to screen these small molecule chemical entities against biological targets of interest for drug discovery or for chemical biology outcomes. It has two core automation systems, the Hamilton MicroSTAR and PerkinElmer Minitrak IX systems as [...]

A member of the RNAi Global Initiative, the Functional Genomics Group at the Peter MacCallum Cancer Centre is open to the Australian medical research community for the purpose of providing access to both small interfering (siRNA) and lentiviral-based short hairpin RNAi (shRNAmir) gene knockdown screens for functional genomics studies.

The ARMI FishCore facility is the largest zebrafish facility of its kind in the southern hemisphere, consisting of 1000 quarantine tanks and 5200 main facility tanks (non quarantine). Fishcore houses genetically modified and mutant strains of zebrafish that model a variety of human diseases and conditions.  It is an approved [...]

MARP facilities supply and accommodate a wide range of animals for research and teaching projects, including mice, rats, rabbits and sheep. Genetically modifies mice are available for use by clients as models for human disease states. MARP can provide clients with help in importation of novel trasgenic models through its [...]

The Australian Phenome Bank (APB) has established, and maintains, a mouse strain archive. It offers Australian researchers a free of charge* mouse sperm and subsidised embryo* cryopreservation service.  The APB also provides and maintains a central database of genetically modified mice held in Australia either live or as cryopreserved material. [...]

The Drug Delivery Disposition and Dynamics (D4) Theme at the Monash Institute of Pharmaceutical Sciences provides expertise and infrastructure in drug formulation and drug delivery system design and assessment and evaluation of drug formulations/delivery systems in pre-clinical animal models. The facility has particular expertise in overcoming the challenges associated with [...]